Cointime

  • 最新情報
  • ニュース
  • 通貨
  • Columns
  • イベント
  • Bitcoin $104,191.38 -1.70%
  • Ethereum $2,535.28 -4.17%
  • BNB $657.03 -2.95%
  • Optimism $0.63 -14.83%
  • Arbitrum $0.34 -16.16%
  • Solana $157.32 -5.93%
  • Polygon $0.22 +2.77%
  • Cosmos $4.29 -7.86%
  • Avalanche $20.68 -7.98%
  • Bitcoin $104,191.38 -1.70%
  • Ethereum $2,535.28 -4.17%
  • BNB $657.03 -2.95%
  • Optimism $0.63 -14.83%
  • Arbitrum $0.34 -16.16%
  • Solana $157.32 -5.93%
  • Polygon $0.22 +2.77%
  • Cosmos $4.29 -7.86%
  • Avalanche $20.68 -7.98%
Home / Nimbus Therapeutics / investors

Nimbus Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
7
17
Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Access Biotechnology - Series Unknown
Atlas Venture - Series Unknown
Bain Capital Life Sciences - Series Unknown
Bill Gates - Series Unknown
Biotechnology Value Fund - Series Unknown
Lightstone Ventures - Series Unknown
Pfizer Venture Investments - Series Unknown
RA Capital Management - Series Unknown
SR One - Series Unknown
SV Health Investors - Series Unknown
Commodore Capital - Series Unknown
Logos Capital - Series Unknown
Surveyor Capital - Series Unknown
BVF Partners - Series Unknown
Lilly Ventures - Series C
Schrödinger - Series C
Richard Friesner - Seed

Contact

Cambridge,Massachusetts,United States
(857) 999-2009
Cointime
Content
  • 最新情報
  • スタートアップ
  • 業界ニュース
  • テクノロジー
  • イベント
Company
  • 会社概要
  • 広告
  • 免責事項
  • © 2023 Cointime. 無断転載禁止
  • プライバシーポリシー
  • 利用規約
Cointime

Recently Searched

Hot Coins

Trending

毎日の必読